Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] - BSA and Azide free
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal RIP3 phospho S232 + T231 antibody. Carrier free. Suitable for Dot, WB and reacts with Synthetic peptide, Mouse samples. Cited in 1 publication.
View Alternative Names
Rip3, Ripk3, Receptor-interacting serine/threonine-protein kinase 3, RIP-like protein kinase 3, Receptor-interacting protein 3, RIP-3, mRIP3
- WB
Unknown
Western blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] - BSA and Azide free (AB240399)
This data was developed using ab222320, the same antibody clone in a different buffer formulation.
Blocking/Dilution buffer : 5% NFDM/TBST.
The higher MW bands in Lanes 1 and 2 are extra bands.
The lysates were prepared following the 1% SDS Hot Lysate buffer method.
For Lysate preparation protocol, please refer to the protocol section of the website and/or here.
All lanes:
Western blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] - BSA and Azide free (ab240399) at 1/1000 dilution
Lane 1:
Untreated L-929 (mouse connective tissue fibroblast cell line) whole cell lysate at 10 µg
Lane 2:
L-929 (mouse connective tissue fibroblast cell line) whole cell lysate treated with 20 ng/ml TNF-a, 100 nM Smac mimetic and 20 μM z-VAD for 6 hours at 10 µg
Lane 3:
L-929 (mouse connective tissue fibroblast cell line) whole cell lysate treated with 20 ng/ml TNF-a, 100 nM Smac mimetic and 20 μM z-VAD for 6 hours, then treated with alkaline phosphatase for 1 hour at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 57 kDa
Observed band size: 53 kDa
false
Exposure time: 30s
- WB
Lab
Western blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] - BSA and Azide free (AB240399)
This data was developed using ab222320, the same antibody clone in a different buffer formulation.
Blocking/Dilution buffer : 5% NFDM/TBST.
Cells were lysed in 4% SDS buffer (4% SDS,10% 2-ME, 20% glycerol, 0.004% Bromophenol blue, Tris-HCl).
The images were kindly provided by our collaborator Dr. Jiahuai Han, Xiamen University.
All lanes:
Western blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] - BSA and Azide free (ab240399) at 1/500 dilution
Lane 1:
Untreated L-929 (mouse connective tissue fibroblast cell line) whole cell lysate at 20 µg
Lane 2:
L-929 (mouse connective tissue fibroblast cell line) whole cell lysate treated with 10 ng/ml TNF-a and 20 µM z-VAD for 2 hours at 20 µg
Lane 3:
L-929 (mouse connective tissue fibroblast cell line) whole cell lysate treated with 10 ng/ml TNF-a and 20 µM z-VAD for 3.5 hours at 20 µg
Lane 4:
L-929 (mouse connective tissue fibroblast cell line) whole cell lysate treated with 20 ng/ml TNF-a, 100 nM Smac mimetic and 20 µM z-VAD for 6 hours at 20 µg
Lane 5:
L-929 (mouse connective tissue fibroblast cell line) whole cell lysate with RIP3 KO cells treated with 20 ng/ml TNF-a, 100 nM Smac mimetic and 20 µM z-VAD for 6 hours at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/5000 dilution
Predicted band size: 57 kDa
false
Exposure time: 60s
- WB
Supplier Data
Western blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] - BSA and Azide free (AB240399)
This data was developed using ab222320, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer concentration : 5% NFDM/TBST.
ab181602 GAPDH was used as a loading control at 1/1000000 dilution.
We recommend involving downstream protein p-MLKL as a control to validate the stimulation of p-RIP3.
Lanes 1 - 4:
Western blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] (<a href='/en-us/products/primary-antibodies/rip3-phospho-t231-s232-antibody-epr19403-52-ab222320'>ab222320</a>) at 1/1000 dilution
Lanes 5 - 8:
Western blot - Anti-MLKL (phospho S345) antibody [EPR9515(2)] (<a href='/en-us/products/primary-antibodies/mlkl-phospho-s345-antibody-epr95152-ab196436'>ab196436</a>) at 1/1000 dilution
Lanes 1, 3, 5 and 7:
Untreated L-929 (mouse connective tissue fibroblast cell line) whole cell lysate at 20 µg
Lanes 2 and 6:
L-929 (mouse connective tissue fibroblast cell line) treated with 20 ng/ml TNF-a, 100 nM Smac mimetic and 20 μM z-VAD for 8 hours whole cell lysate at 20 µg
Lanes 4 and 8:
L-929 (mouse connective tissue fibroblast cell line) treated with 20 ng/ml TNF-a, 100 nM Smac mimetic and 20 μM z-VAD for 6 hours whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 57 kDa,54 kDa
Observed band size: 53 kDa
false
Exposure time: 180s
- Dot
Lab
Dot Blot - Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52] - BSA and Azide free (AB240399)
Dot blot analysis of RIP3 (phospho T231 + S232) labeled with ab222320 at 1/1000 dilution.
Lane 1 : RIP3 (phospho T231 + S232) peptide (aa229-239);
Lane 2 : RIP3 (phospho T231 + S232) peptide (aa223-236);
Lane 3 : RIP3 (phospho T231) peptide (aa223-239);
Lane 4 : RIP3 (phospho S232) peptide (aa223-239);
Lane 5 : RIP3 non-phospho peptide (aa223-239).
Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution was used as secondary antibody.
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : 3 minutes.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab222320).
Related conjugates and formulations (1)
-
Anti-RIP3 (phospho T231 + S232) antibody [EPR19403-52]
Reactivity data
Product details
ab240399 is the carrier-free version of ab222320.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
RIP3 facilitates the execution of necroptosis a form of programmed cell death distinct from apoptosis. It becomes activated upon binding with RIP1 forming a necrosome complex that is essential for this pathway. This complex promotes phosphorylation events that subsequently lead to membrane rupture and cell death. Apart from its role in necroptosis RIP3 also engages in metabolic regulation processes linking energy status and cell death under conditions of stress.
Pathways
RIP3 is a principal component of the necroptotic pathway interacting closely with RIP1 to trigger cell death in conditions where caspase activation is inhibited. Alternatively it integrates into metabolic pathways participating in sensing and responding to changes in cellular energy states. The interplay between RIP3 and RIP1 within these pathways illustrates their shared involvement in maintaining cellular homeostasis and triggering cell death when necessary.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 13:15508 PubMed37726363
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com